Orion Portfolio Solutions LLC Invests $65,000 in The Beauty Health Company (NASDAQ:SKIN)

Orion Portfolio Solutions LLC bought a new stake in shares of The Beauty Health Company (NASDAQ:SKIN) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 44,870 shares of the company’s stock, valued at approximately $65,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Federated Hermes Inc. increased its position in shares of Beauty Health by 349,616.0% during the second quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock worth $712,000 after purchasing an additional 370,593 shares in the last quarter. Cohen Capital Management Inc. increased its position in Beauty Health by 344.1% during the 3rd quarter. Cohen Capital Management Inc. now owns 572,848 shares of the company’s stock valued at $825,000 after buying an additional 443,859 shares in the last quarter. FMR LLC raised its stake in Beauty Health by 0.3% in the third quarter. FMR LLC now owns 18,603,037 shares of the company’s stock valued at $26,788,000 after buying an additional 58,826 shares during the last quarter. Caprock Group LLC acquired a new stake in Beauty Health in the second quarter worth about $38,000. Finally, Bank of New York Mellon Corp boosted its holdings in Beauty Health by 24.9% in the second quarter. Bank of New York Mellon Corp now owns 348,108 shares of the company’s stock worth $668,000 after acquiring an additional 69,329 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Performance

Shares of SKIN opened at $1.46 on Friday. The company has a debt-to-equity ratio of 9.23, a quick ratio of 5.57 and a current ratio of 6.56. The stock has a 50-day moving average of $1.58 and a two-hundred day moving average of $1.65. The stock has a market cap of $181.22 million, a P/E ratio of -3.48 and a beta of 0.85. The Beauty Health Company has a one year low of $0.91 and a one year high of $5.17.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group increased their price objective on shares of Beauty Health from $1.25 to $1.75 and gave the company a “hold” rating in a research report on Wednesday, November 13th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $2.55.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.